Dual antiplatelet therapy and non-cardiac surgery: evolving issues and anesthetic implications

Dual antiplatelet therapy (DAPT) consisting of aspirin plus a P2Y(12) inhibitor (clopidogrel, prasugrel, or ticagrelor) is imperative for the treatment of acute coronary syndrome, particularly during the re-endothelialization period after percutaneous coronary intervention (PCI). When patients under...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Jong Wook, Soh, Sarah, Shim, Jae-Kwang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Anesthesiologists 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5296381/
https://www.ncbi.nlm.nih.gov/pubmed/28184261
http://dx.doi.org/10.4097/kjae.2017.70.1.13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5296381/
https://www.ncbi.nlm.nih.gov/pubmed/28184261
http://dx.doi.org/10.4097/kjae.2017.70.1.13

Ejemplares similares